Efficient Near Infrared Light Triggered Nitric Oxide Release Nanocomposites for Sensitizing Mild Photothermal Therapy

Mild photothermal therapy (PTT), as a new anticancer therapeutic strategy, faces big challenges of limited therapeutic accuracy and side‐effects due to uneven heat distribution. Here, near infrared triggered nitric oxide (NO) release nanocomposites based on bismuth sulfide (Bi(2)S(3)) nanoparticles and bis‐N‐nitroso compounds (BNN) are constructed for NO‐enhanced mild photothermal therapy. Upon 808 nm irradiation, the high photothermal conversion efficiency and on‐demand NO release are realized simultaneously. Due to the unique properties of NO, enhanced antitumor efficacy of mild PTT based on BNN‐Bi(2)S(3) nanocomposites is achieved in vitro and in vivo. Mechanism studies reveal that the exogenous NO from BNN‐Bi(2)S(3) could not only impair the autophagic self‐repairing ability of tumor cells in situ, but also diffuse to the surrounding cells to enhance the therapeutic effect. This work points out a strategy to overcome the difficulties in mild PTT, and has potentials for further exploitation of NO‐sensitized synergistic cancer therapy.